These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 1239563)
21. [Lung involvement in connective tissue inflammation]. Danieli G; Montroni M; Corvetta A; Bartocci C Minerva Med; 1981 Dec; 72(50):3441-9. PubMed ID: 7322404 [No Abstract] [Full Text] [Related]
22. [A rare case of huge aspergilloma developed within a lesion of pulmonary fibrosis secondary with a systemic scleroderma in an immunocompetent patient in Madagascar]. Rakotoson JL; Vololontiana HM; Raherison RE; Andrianasolo R; Rakotomizao JR; Randria MJ; Rapelanoro RF; Andrianarisoa AC; Rajaona HR Bull Soc Pathol Exot; 2011 Dec; 104(5):325-8. PubMed ID: 21698483 [TBL] [Abstract][Full Text] [Related]
23. [A study of pulmonary function of idiopathic interstitial pneumonia--pulmonary diffusing capacity and small airway dynamics]. Saito G Nihon Kyobu Shikkan Gakkai Zasshi; 1984 Sep; 22(9):742-50. PubMed ID: 6521087 [No Abstract] [Full Text] [Related]
25. [Autopsy case of pulmonary fibrosis complicated with hypergammaglobulinemia, with special reference to sine scleroderma (without skin manifestations)]. Higuchi M; Nozawa Y; Kitamura S Nihon Rinsho; 1969 Jan; 27(1):201-6. PubMed ID: 4181418 [No Abstract] [Full Text] [Related]
26. Increased serum interleukin 23 in patients with systemic sclerosis. Komura K; Fujimoto M; Hasegawa M; Ogawa F; Hara T; Muroi E; Takehara K; Sato S J Rheumatol; 2008 Jan; 35(1):120-5. PubMed ID: 18085738 [TBL] [Abstract][Full Text] [Related]
27. [Pulmonary fibrosis in diffuse scleroderma]. Yamazaki M; Sato M; Sakai K; Takahashi K Rinsho Hoshasen; 1966 Apr; 11(4):285-91. PubMed ID: 5181040 [No Abstract] [Full Text] [Related]
29. [Treatment of interstitial pulmonary fibrosis with D-penicillamine in progressive scleroderma: a long-term study (author's transl)]. Bröll H; Tausch G; Eberl R Wien Klin Wochenschr; 1976 Apr; 88(9):292-5. PubMed ID: 973388 [TBL] [Abstract][Full Text] [Related]
34. [Fibrosis in systemic diseases (diffuse mesenchymopathies)]. Serdarević H Tuberkuloza; 1967; 19(1):54-60. PubMed ID: 4383790 [No Abstract] [Full Text] [Related]
35. Circulating endothelin-1 levels in systemic sclerosis subsets--a marker of fibrosis or vascular dysfunction? Gordon MM; Madhok R J Rheumatol; 1996 Apr; 23(4):788-9. PubMed ID: 8730151 [No Abstract] [Full Text] [Related]
36. An analysis of connective tissue disease-associated interstitial lung disease at a US Tertiary Care Center: better survival in patients with systemic sclerosis. Su R; Bennett M; Jacobs S; Hunter T; Bailey C; Krishnan E; Rosen G; Chung L J Rheumatol; 2011 Apr; 38(4):693-701. PubMed ID: 21285162 [TBL] [Abstract][Full Text] [Related]
37. Lung cancer and scleroderma. Winkelmann RK; Flach DB; Unni KK Arch Dermatol Res; 1988; 280 Suppl():S15-8. PubMed ID: 2841907 [TBL] [Abstract][Full Text] [Related]